| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0017 | 1 |